Heading,Source,Date,Symbol
USFDA issues warning letter to Sun Pharma's Dadra unit; stock slips 2%,Business Standard,20 Jun 2024,SUNPHARMA
Sun Pharma gets USFDA warning for manufacturing practice violations at Dadra unit; stock extends fall,Moneycontrol,20 Jun 2024,SUNPHARMA
